(Q36669053)

15 August 2017

1 reference

title

Novel insights into vascular calcification (English)

1 reference

15 August 2017

Ketteler M

1

1 reference

15 August 2017

Giachelli C

series ordinal

2

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Kidney International. Supplement

15 August 2017

published in

1 reference

15 August 2017

issue

105

1 reference

15 August 2017

page(s)

S5-9

1 reference

Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Vascular calcification mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Vulnerable plaque: the pathology of unstable coronary lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Arterial stiffness and function in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Vascular calcification: mechanisms and clinical ramifications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Arterial calcification and pathology in uremic patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Phosphate regulation of vascular smooth muscle cell calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Vascular calcification in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Calcification and cardiovascular problems in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Arterial calcifications and bone histomorphometry in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

High-density lipoprotein regulates calcification of vascular cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Aortic and large artery compliance in end-stage renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Cardiac Valve Calcification as an Important Predictor for All-Cause Mortality and Cardiovascular Mortality in Long-Term Peritoneal Dialysis Patients: A Prospective Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Regulation of cardiovascular calcification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001996

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001996

0 references

1 reference